JLF is Growing!
We’re thrilled to announce the opening of two new sites, one in New York, New York and one in Dallas, Texas. making it easier for patients across the US to access the JLF program.
Additionally, we are exploring the possibility of opening a new site in Columbus, Ohio. We are also continuing to enroll patients at our existing locations in San Francisco, Los Angeles, Miami, and St. Louis.
If you know a clinician who may be interested in partnering with the JLF program, please reach out to Emily. We are especially interested in opportunities in Washington, Oregon, Georgia, and North Carolina.
Data Collection Through the Amended Protocol
This past year, JLF received approval from the FDA to expand our research surrounding vaccine efficacy. While this expansion will not affect the services patients receive, there will be a modest price adjustment to support the requirements of the amended protocol. Moving forward, we will focus on increasing our data collection and analysis capabilities, laying the groundwork to share our findings with the JLF community and the broader vaccine research field in the future.
Vaccine Improvement Aspirations
In addition to expanding our research initiatives, our goal is to enhance our vaccine development practices. These efforts are made possible through the generosity of our fundraising supporters and continued progress will depend on sustained donor contributions.
